Skip to content
drillr.ai
Sign up

XTLB

XTL Biopharmaceuticals Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$2.53
+1.20%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue451.0K—451.0K——
Cost of Revenue332.0K—448.0K—1.0K
Gross Profit119.0K—3.0K—(1.0K)
Operating Expenses
R&D Expense98.0K28.0K98.0K31.0K30.0K
SG&A Expense2.0M1.1M2.0M734.0K850.0K
General & Admin Expense1.9M1.1M1.9M734.0K850.0K
Selling & Marketing Expense178.0K—178.0K——
Other Expenses147.0K531.0K31.0K——
Total Operating Expenses2.3M1.7M2.2M765.0K880.0K
Cost and Expenses2.6M1.7M2.6M765.0K880.0K
Operating Income (EBIT)(2.2M)(1.7M)(2.2M)(765.0K)(880.0K)
Non-Operating
Interest Income34.0K60.0K34.0K41.0K36.0K
Interest Expense86.0K7.0K86.0K4.0K11.0K
Net Interest Income(52.0K)53.0K(52.0K)37.0K25.0K
Other Non-Op Income/Expense1.0M929.0K1.0M(1.0M)(468.0K)
Non-Operating Income (excl Interest)(367.0K)(936.0K)(1.0M)——
EBT (Pre-Tax Income)(1.2M)(759.0K)(1.2M)(1.8M)(1.3M)
Income Tax Expense(130.0K)—(130.0K)——
Bottom Line
Net Income(1.0M)(7.0M)(1.0M)(1.8K)(1.3M)
Earnings from Cont. Ops(1.0M)(759.0K)(1.0M)(1.8M)(1.3M)
Earnings from Discont. Ops—(6.2M)———
Bottom Line Net Income(1.0M)(7.0M)(1.0M)(1.8K)(1.3M)
Per Share
Basic EPS($2.88)($17.00)($2.40)($30.00)($4.00)
Diluted EPS($2.88)($16.00)($2.40)($30.00)($4.00)
Revenue Per Share$1.07$0.00$1.07$0.00$0.00
Shares
Basic Shares Outstanding420652420652420652340566340568
Diluted Shares Outstanding440101440101440101340566340568
Profitability Metrics
EBITDA(791.3K)(752.0K)(930.0K)(764.0K)(879.0K)
D&A528.8K—199.0K1.0K1.0K
EBIT(1.1M)(752.0K)(1.1M)(765.0K)(880.0K)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025